The mechanism by which circulating human basophils adhere to vascular endothelium and migrate to sites of allergic reactions is unknown. Agents have been identified which stimulate the adherence of purified basophils to cultured human umbilical vein vascular endothelial cells (HuVEC). Treatment of HuVEC with interleukin 1, tumor necrosis factor (TNF), bacterial endotoxin, and 12-O-tetradecanoylphorbol-13-acetate (TPA) resulted in time and dose-dependent increases of adhesiveness for basophils. Coincubation of basophils and HuVEC for 10 min with C5a, formyl-methionyl-leucyl-phenylalanine, the calcium ionophore A23187, platelet-activating factor, TNF, and TPA also resulted in significant dose-dependent increases in basophil adherence; this effect resulted from activation of the basophil. Adherence of basophils to HuVEC was time and temperature dependent, required divalent cations, and was unaffected by glucocorticoids. Monoclonal antibody 603, directed against the a-subunit of the leukocyte adherence complex CD18, inhibited the binding of basophils to HuVEC.
Introduction
A variety of inflammatory responses in animals and man are accompanied by increased numbers of basophils. In guinea pigs, for example, the delayed local accumulation of large numbers of basophils after appropriate intracutaneous sensitization with heterologous proteins is termed cutaneous basophil hypersensitivity (1) . In man, basophils have long been known to be important in atopic diseases, but their specific role in these reactions remains uncertain. Histamine release after allergen challenge of peripheral blood basophils has become firmly established as an in vitro model for immediate hypersensitivity, and correlates with the clinical manifestations of chronic allergic diseases such as symptom scores and skin test results (2, 3) . Immediate type hypersensitivity reactions in the skin, nose, and lower airways, once thought to be an isolated monophasic response, are often followed in 3-12 h by the gradual reappearance ofa more sustained inflammatory reaction (4) . Histological evaluation ofthese late phase allergic reactions in the skin and nose demonstrated a characteristic intense cellular infiltrate composed of neutrophils and eosinophils, as well as basophils (5, 6) . Increases in the number of circulating basophils reportedly precede exacerbations of asthma, and increased numbers of basophils have also been found in vernal conjunctivitis, atopic and contact dermatitis, bronchial and nasal secretions, peripheral blood, skin test sites, and skin windows after allergen stimulation in allergic subjects (reviewed in reference 7). After intranasal antigen challenge, the release of histamine, which coincides with symptoms during the late phase, is not accompanied by a rise in prostaglandin D2, suggesting that histamine released during the nasal late phase response is from basophils rather than mast cells (8) .
The fact that basophils and basophil-derived mediators appear during inflammatory reactions suggests that mechanisms exist for the recruitment of basophils to the sites of these responses. This requires that circulating basophils first adhere to the vascular endothelium; subsequent diapedesis and chemotaxis then results in their appearance in the inflammatory infiltrate. This implies the existence of mechanisms for basophil chemotaxis, diapedesis, and/or adherence to vascular endothelium. While investigators have previously identified stimuli, including C5a, lymphokines, and serum from allergic donors, which are chemotactic for human basophils (9) (10) (11) (12) , there currently is no information regarding the mechanisms and regulation of basophil adherence to vascular endothelium.
Recently, techniques for the isolation and culture of human vascular endothelial cells (HuVEC)' from umbilical veins have enabled investigators to identify agents such as interleukin 1 (IL 1), tumor necrosis factor (TNF), lymphotoxin, bacterial endotoxin, and tumor promoting phorbol diesters that promote the adherence of neutrophils, eosinophils, and mononuclear cells by inducing the transient de novo expression of specific proteins on the surface of HuVEC (13) (14) (15) (16) (17) (18) (19) . At least one such protein, termed E-LAM-1, has now been identified using monoclonal antibodies (20) . Leukocyte adherence to endothelium and other substrates appears to be mediated through a family of adherence molecules normally present on the leukocyte cell surface; these molecules include the Mo 1, LFA-1, and p50O,95 glycoproteins, collectively referred to as the CD 18 antigens (21, 22) . Recent reports have demonstrated the presence ofMo 1 and LFA-1 antigens on the surface 1. Abbreviations used in this paper: DMSO, dimethylsulfoxide; HuVEC, human vascular endothelial cells; IFN, interferon-y; LPS, E. coli lipopolysaccharide; PAF, platelet-activating factor (I-alkyl-2-acetyl-sn-glycero-3-phosphocholine); PAG, Pipes-buffered saline with 0.003% human serum albumin and 0.1% D-glucose; PAGC, PAG containing 1 mM CaCl2; PAGCM, PAG containing 1 mM CaC12 and 1 of human basophils, but p150,95 is apparently absent (23). Agents such as the bacterial peptide fMLP, the complement fragment C5a, calcium ionophore A23187, and phorbol diesters also stimulate leukocyte adherence, apparently by rapidly upregulating the number of preformed CD 18 glycoproteins on the surface of the leukocyte (24) (25) (26) . It remains uncertain whether CD 18 antigens on leukocytes bind directly to endothelial cell E-LAM-1 antigens, but it is clear that separate mechanisms exist for the activation ofleukocytes and endothelium to facilitate their adhesive interactions. We therefore have examined a variety of stimuli for their ability to promote basophil adherence to HuVEC. Several stimuli have been identified that act on HuVEC to induce adhesiveness for basophils. Additional stimuli have been found that promote basophil adherence by an effect primarily on the basophil. Since glucocorticoids are known to prevent the accumulation of leukocytes at inflammatory sites by inhibiting their adherence to the vascular endothelium, the effect of dexamethasone and hydrocortisone treatment of basophils on their ability to adhere to HuVEC has been studied. Finally, several aspects of basophil-HuVEC adherence have been characterized, including the kinetics of adherence, and dependence on temperature, divalent cations, and CD 18 antigens.
Isolation and culture of human umbilical vein endothelial cells. HuVEC were isolated from umbilical cord veins after collagenase digestion and grown in primary culture in Ml 99 media supplemented with 20% fetal calf serum, antibiotics, heparin, and endothelial cell growth factor as previously described ( 14) . No cell lines were passaged more than three times. Endothelial cells were allowed to grow to confluence on gelatinized 24-well culture plates (-250 [33] ). After incubation, the supernatants were harvested, centrifuged to remove cells, and saved for histamine analysis. The wells were then rinsed once with 1 ml warm buffer to remove any remaining nonadherent cells. 1 ml of 1.6% perchloric acid was then added to each well to lyse adherent basophils and precipitate proteins. Histamine content of supernatants and adherent cells was quantitated using an automated fluorometric assay (34) . Percent histamine release and percent basophil adherence was then calculated by comparison to the histamine content of the starting basophil suspension after perchlorate lysis. All experiments were performed in duplicate, and replicates were excellent, with a coefficient of variation < 10%.
To verify histamine recovery and demonstrate that histamine was neither metabolized nor adsorbed to plastic, gelatin, or endothelial cells, histamine in concentrations up to 25 ng/ml was added to rinsed monolayers of HuVEC after a 4-h incubation with IL 1 (4 U/ml), LPS (100 ng/ml), TNF (1 ng/ml), TPA (30 ng/ml), or medium alone. After a 10-min incubation (37°C, 5% C02, 95% air), supernatants were recovered and analyzed for histamine. Recovery of exogenously added histamine exceeded 95% (n = 3). Similarly, greater than 90% of the histamine present in an aliquot of basophils added during the adherence assay could be accounted for after combining the amount of histamine released with the histamine content of adherent and nonad-1356 herent cells. Adherence of purified basophils to HuVEC was verified using phase-contrast microscopy and was not due to leukocyte aggregation or adherence to plastic or gelatin under the assay conditions used. Alcian blue staining of adherent cells clearly revealed binding of individual basophils to cultured endothelial cells. Incubations of basophils with HuVEC for 20 min or longer, however, occasionally resulted in cell aggregation (see Results).
The second type of adherence assay was designed to examine the ability of agents to stimulate basophil adhesiveness. Because most of the stimuli that promote leukocyte-dependent adherence are secretagogues, significant histamine release would make measurements ofthe histamine content of adherent cells an invalid estimate of basophil adherence. However, since adherence of basophils to HuVEC can occur in the absence of calcium as long as magnesium is present (see Results), PAGM buffer was used in these experiments to prevent calcium-dependent histamine release that may have occurred with many of these stimuli. Unfortunately, attempts to separately pretreat small aliquots of basophils with these stimuli were unsuccessful due to problems with cell recovery and aggregation. Therefore, the ability of various stimuli to effect basophil adhesiveness to unstimulated HuVEC was assessed by coincubating HuVEC (washed once with I ml PAGM) with stimulus and 2-4 X 104 basophils (final volume 555 Ml) at 370C for 10 min in a humidified atmosphere of 5% CO2, 95% air. To examine whether HuVEC activation was occurring in this assay, other experiments were performed in which HuVEC alone were preincubated with these same stimuli for 10 min. The stimuli were then either removed or allowed to remain to coincubate with basophils during a subsequent 10-min adherence assay. Supernatants were then harvested, nonadherent cells removed by rinsing once with 1 ml PAGM, adherent cells were lysed, and histamine release and liberated cell-associated histamine quantitated as above. Under these conditions, histamine release did not occur. In all experiments, appropriate dilutions of stock solution vehicles for each stimulus were tested and found to have no effect on basophil histamine release or adherence to HuVEC in either assay. was added (final antibody concentration: 44 gg/ml). Cells were allowed to incubate (370C, 95% air, 5% CO2) for 10 min, nonadherent cells were rinsed, adherent cells lysed, and liberated cell-associated histamine measured as above. Experiments were performed in a smaller final incubation volume than other experiments in order to conserve reagents. In these assays, neither monoclonal antibody caused histamine release.
Effect oftemperature and divalent cations on basophil adherence to Hu VEC. To examine the effect of temperature on basophil adherence, HuVEC were first preincubated as above for 4 h at 370C with optimal concentrations of several stimuli; HuVEC were then washed with PAGCM at 4°, 22°, or 370C, and 0.5 ml of buffer at the appropriate temperature was added. Adherence assays were performed by adding basophils (100 ul) suspended in PAGCM buffer (220C); leukocytes were allowed to adhere to HuVEC for 10 min at the appropriate temperature (refrigerator, bench-top, or incubator), and basophil adherence quantitated as above.
To examine the effect of divalent cations on basophil adherence, HuVEC were preincubated as above and washed with warm buffer (PAG, PAGC, PAGM, or PAGCM); 0.5 ml of appropriate buffer was then added. Basophils (100 1L) suspended in appropriate buffer at 370C were then added, allowed to adhere at 370C (5% CO2, 95% air) for 10 min, and adherence quantitated as above.
Results
Endothelial cell stimulation enhances adhesiveness for basophils. Prior experiments have shown that stimuli such IL 1, LPS, TNF, and TPA induce optimal adhesiveness in HuVEC for neutrophils within 4 h of incubation (14) . We therefore tested the ability of these stimuli to promote adhesiveness in HuVEC for basophils by preincubating HuVEC for 4 h; after washing the HuVEC, basophils were added, and allowed to adhere to HuVEC for 10 min. Data in Fig. 1 demonstrate that in the absence ofstimulus, basophil adherence was 20.8±3.0%, while IL 1, LPS, TNF, and TPA produced dose-dependent increases in adherence of basophils to HuVEC. Optimal binding of basophils to HuVEC was induced by 4 U/ml IL 1 (38.4±3.8%), 100 ng/ml LPS (44.2±6.9%), 1 ng/ml TNF (45.1±5.4%), and 30 ng/ml TPA (62.7±3.5%). At no time did adherence of basophils to HuVEC result in histamine release above that of background spontaneous release (top, Table I and data not shown). Stimuli such as PAF (0.1-1 -M), IFN (1-10 ng/ml), and IL 2 (1-100 U/ml) did not induce adhesiveness in HuVEC for basophils (combined average for highest concentrations tested: 1 16±4% of control, n = 3).
The kinetics of the acquisition of adhesiveness in HuVEC for basophils is shown in Fig. 2 . Adhesiveness in HuVEC induced by IL 1, LPS, and TNF were similar, being half-maximal by 2 h, and optimal after 4-6 h of incubation. Adherence induced by exposure of HuVEC to TPA was more rapid, with half-maximal and maximal increases after 15-30 min and 2 h, respectively. Adhesiveness induced by all four stimuli gradually declined over 24 h, but did not return to unstimulated values. To assess the role of protein and RNA synthesis in the acquisition of adhesiveness for basophils, two experiments were performed in which HuVEC were pretreated for 15 min with a protein synthesis inhibitor (cycloheximide, 1 ug/ml) or an RNA synthesis inhibitor (actinomycin D, 1 gg/ml) and then coincubated for 4 h without stimulus or with IL 1 (2 U/ml), TNF (1 ng/ml) or TPA (10 ng/ml). Neither drug affected unstimulated adhesiveness (103±4 and 119±4% of controls, respectively). Cycloheximide inhibited the increase induced by IL 1 and TNF (23±6 and 38±1% inhibition, respectively) while having little activity in preventing TPA-induced adhesiveness (7±7% inhibition). Actinomycin D was more effective in blocking adhesiveness induced by TNF than by TPA (94±6 vs. 26±26% inhibition). In the presence of IL 1, actinomycin D was toxic for HuVEC, an effect that has been previously observed (35). In the studies displayed in Figs. 1 and 2 , a 10-min incubation of basophils with HuVEC was used. However, as seen in Fig. 3 , the adherence of basophils to HuVEC was time dependent, with increased adherence that was detectable after 5 min, and maximal by 40 min. Cell aggregation was occasionally observed microscopically when incubation periods exceeded 20 min. Since longer incubation times may also allow leukocyte diapedesis and chemotaxis to occur, values at these longer time points may not simply reflect basophil-HuVEC adherence. Therefore, a 1 0-min incubation was used in all subsequent studies. As shown in Figs. 4 (36) . Under these conditions, lyso-PAF and anti-IgE did not increase basophil adherence. With the stimuli used, exposure ofbasophils to stimulus was necessary to increase adherence, since preincubation of HuVEC alone for 10 min, removal of the stimulus, and subsequent addition of basophils did not result in increased basophil adherence (Table II) . Preincubation of HuVEC with stimuli for 10 min resulted in less basophil adherence than simultaneous addition of stimulus and basophils.
Basophil adherence to HuVEC is CD18-dependent. Adherence of other leukocyte subpopulations has been shown to be due to a CD18-dependent mechanism (16, 22, 37 Figure 2 . Kinetics of induction of adhesiveness in HuVEC for basophils. HuVEC were incubated with TPA (n, 30 ng/ml), IL 1 (Ei, 4 U/ml), TNF (*, 1 ng/ml), LPS (o, 100 ng/ml), or PAGCM (o) diluent for the amount of time indicated, and then tested for adherence of basophils (2 and 4% purity) as in Fig. 1 . Values represent the mean±SEM of duplicate determinations in two experiments.
lime (min) Figure 3 . Kinetics of adherence of basophils to HuVEC. HuVEC were pretreated as in Fig. 2 Figure 6 . Effect of glucocorticoids on basophil adherence to HuVEC. Basophils (2-13% purity) were cultured for 20 h with 1 AM hydrocortisone (0), dexamethasone (m), or medium alone (o, control), washed, and then allowed to adhere for 10 min to HuVEC pretreated as in Fig. 2 (41, 42) . The reason for the observed difference in cation requirements between calcium and magnesium seen only with unstimulated and TPA-induced adherence is unclear. Both unstimulated and maximally stimulated basophil adherence to HuVEC was greater than that previously reported for other granulocytes ( 14) . The concentrations of the stimuli used that induce maximal adherence are similar for basophils, neutrophils, and eosinophils, except that approximately one-tenth the concentration of LPS is required for optimal adherence of basophils (14, 16) . It is unclear whether the relative differences between the adherence of basophils and other granulocytes to HuVEC represents a true difference, or whether this simply reflects subtle differences in the adherence assays (e.g., leukocyte density) or methods used for leukocyte purification (e.g., isolation of basophils in the absence of serum), experimental conditions that result in activation of other basophil functions such as releasability (43) . We also noted some donor-dependent variability in unstimulated adherence, suggesting the possibility of as yet undefined factors influencing endogenous basophil adhesiveness.
In these studies, culture with glucocorticoids was shown to have no effect on the ability of basophils to adhere to HuVEC. This is in agreement with studies on neutrophils, which further demonstrated that glucocorticoid treatment failed to inhibit the acquisition of adhesiveness in HuVEC stimulated by similar agents (44). Therefore, since glucocorticoids are known to inhibit cell accumulation during inflammatory reactions (such 1360 Bochner, Peachell, Brown, and Schleimer and secretagogues (fMLP, CSa, TPA, and the calcium ionophore A23 187) increase adherence as a result of increasing the expression of CD 18 glycoproteins oil the surface of these cells (24) (25) (26) . More recently, other stimuli lacking secretagogue activity have also been shown to promote leukocyte-dependent increases in adhesiveness, such as TNF and PAF (15, 16, 46) . To examine this aspect of basophil adherence, experiments were performed in the absence of calcium, since inclusion of this cation would have resulted in basophil degranulation and histamine release (36) , making it impossible to accurately measure basophil adherence by the methods used in our studies. Due to technical constraints, the protocol used for these studies required the coincubation of leukocytes with HuVEC in the presence of stimuli; it is therefore possible that these stimuli could also have an acute effect on HuVEC. As shown in Table II , pretreatment ofHuVEC with stimuli for 10 min and removal of the stimulus before the addition of basophils led to minimal changes in adherence, suggesting that stable activation of adhesiveness in HuVEC does not occur with these stimuli. While the most direct interpretation of these results is that the basophils are being activated to increase adherence, it is also possible that nonbasophilic leukocytes in the preparation are stimulated to release other factors which then influence basophil-HuVEC adhesiveness. Furthermore, the observation that preincubation of HuVEC with stimuli is less effective than coincubation alone suggests the possibility of degradation or uptake of stimuli by HuVEC or plastic, or the production by HuVEC of an inhibitor of adherence, an idea that is not without precedence (47) .
It is of note that calcium was not necessary for basophildependent stimulation of adherence, and increased basophil adhesiveness can occur without degranulation. The with neutrophils have demonstrated a rapid increase (i.e., within minutes) in the number of CD1 8 surface antigens after treatment with similar stimuli which is not prevented by inhibitors of messenger RNA or protein synthesis (25, 48) . This has led to the hypothesis that there is a preformed intracellular pool of CD18 receptors (perhaps located in the secondary or "6tertiary granules in the neutrophil) which can be rapidly translocated to the cell surface (25, (48) (49) (50) . Additional experiments are currently in progress to determine whether basophil expression of CD 18 antigens and adhesiveness increases during degranulation; it will also be interesting to examine whether IgE-dependent stimulation of basophils (in the presence of calcium) can alter their adhesiveness.
Of particular interest was our findings that PAF, but not lyso-PAF, was capable of stimulating basophil adherence to HuVEC. To our knowledge, this is the first reported evidence that basophils respond to PAF, and suggests that this mediator may potentially be important in modulating other basophil functions. Extensive studies on the effects of PAF on basophil histamine release have consistently revealed no effect (data not shown). In addition, HuVEC are known to produce PAF in response to a variety of stimuli including IL 1 (51). While this may have contributed to the adhesive changes seen with basophils, whether the stimuli and experimental conditions used in our studies caused significant production of endothelial cell PAF was not determined.
We have also demonstrated that coincubation of basophils with an antibody directed against the common P subunit ofthe Fig. 7 . While the mechanisms for late phase allergic responses remain unclear, stimulation of adhesiveness in vascular endothelium may be an important initiating factor in the development of the characteristic influx of granulocytes. Since granulocytes appear to share similar molecular mechanisms for adherence, it seems likely that it is the combined actions of both adherence-promoting factors and specific chemotactic factors which are required for the development of a specific cellular infiltrate. The delayed nature of late phase allergic reactions in vivo might therefore be due to the time necessary for both the production of endothelial cell activating factors and their subsequent action on vascular endothelium. Interactions with chemotactic factors, many of which are secretagogues, may also directly promote basophil adhesiveness and recruitment. The recent demonstration of a rare syndrome characterized by recurrent bacterial infections, impaired wound healing, gingivitis, and diminished pus formation has led to the discovery of a genetic deficiency in CD18 expression (24) (25) (26) 28 
